Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05025735
Status:
UNKNOWN
Last Update Posted:
2021-10-19
First Post:
2021-06-26
Brief Title:
Alpelisib Fulvestrant and Dapagliflozin for the Treatment of HR HER2 - PIK3CA Mutant Metastatic Breast Cancer
Sponsor:
Organization:
Saint Lukes Health System